The expanding capability and clinical relevance of molecular diagnostic technology to identify and evaluate EGFR mutations in advanced/metastatic NSCLC
Parth Shah(Dartmouth–Hitchcock Medical Center), Nicola Normanno(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Jacob Sands(Harvard University)
Cited by 8
Related Papers
Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
|The Journal of Immunology|2011|894
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|459
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
|Annals of Oncology|2024|343
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
|Journal of Clinical Oncology|2024|177
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
|European Journal of Cancer|2021|174